PPT-Large scale evidence generation for the utilisation and safety of biologic medicines

Associate Professor Nicole Pratt Quality use of medicines and pharmacy research centre University of South Australia overview Biologic medicines or immune based therapies are a rapidly evolving group of pharmaceutical products whose active component is biologically derived rather than chemically synthesised . By. Chi . Bemieh. . Fule. August 6, 2013. THESIS PRESENTATION . Outline. . of. . today’s. presentation. Justification of the study. Problem . statement. Hypotheses. Conceptual. . framework. Research . Azusa Sato. London School of Economics, UK. Introduction. Traditional medicines (TM)/healers: WHO. ‘the knowledge, skills and practices based on the theories, beliefs and experiences indigenous to different cultures, used in the maintenance of health and in the prevention, diagnosis, improvement or treatment of physical and mental illness’. David Wallom . Overview. The problem…. Other communities. The pace of technological change. Using the data. The problem…. New telescopes generate vast amounts of data. Particularly (but not limited to) surveys (SDSS, PAN-STARRS, LOFAR, SKA…). a Virtual Biologics Clinic. Dr Ben Parker PhD, MRCP. Consultant Rheumatologist, Manchester Royal Infirmary. Honorary Senior Lecturer, University of Manchester. To cover. Why the need for innovation in biologics services?. Presented by . the Alliance for Safe Bioloigic . Medicines & the Global Colon Cancer Association. . . . . Andrew Spiegel, Esquire. . . andrew.spiegel@globalcca.org. THANK YOU! . Concept/Process and Update on EML 2015. WHO Technical Briefing Seminar. Nicola Magrini – WHO, EMP. November 4, 2014 – WHO Geneva. Essential Medicines. Guiding principle:. . A limited range of carefully selected essential medicines leads to better health care, better medicines management, and lower costs. August, 2014. Biologics & Biosimilars: . An Overview. 1. What is a biologic?. 2. Biologics Are Complex. Biologics are innovative medications that aren’t made, they are grown in living cells. . Biologics are complex molecules– up to 1,000 times larger than conventional medicines. . Ms. Leah Goodman. Contents. Key Messages. An Overview - Biological Medicines and their Regulatory Framework. PhAMA Position and Recommendation on Biosimilars . An Overview - Biological Medicines and their Regulatory Framework. Introduction. Case 1: When to Start a Biologic?. Case 1: When to Start a Biologic? (cont). Case 1: When to Start a Biologic? (cont). Case 1: When to Start a Biologic? (cont). Case 1: When to Start a Biologic? (cont). The . HDA (formerly BAPW) . Who we are. Good Distribution Practice . HDA is a UK-wide representative trade association whose mission is to advance the interests and values of those member companies who provide . UKMi Horizon Scanning Working Group. Jim Glare. West Midlands Medicines Information Service. 11-Nov-2018. Objectives. This presentation aims to give some understanding of:. the ‘life-cycle’ of a medicine. Industry Engagement Workshop 2. Application of Next Generation Technologies. 20 January 2022. The background fill can also be changed to an image. (Right click on the slide and select “Format Background…”). Welcome to the monthly web meeting . Wednesday 31. st. August 2022. The meeting will start at 1pm. Web meeting process. Welcome to our monthly meeting using MS Teams. Please use the chat box to comment, share your experiences and ask questions.. Basic enquiry answering. September . 2016. Session aims. Increase awareness of the Medicines Information (MI) services. UK. Wales. Increase awareness of the questions to ask an enquirer. Have practical experience using some resources which will be...